NVTA
NVTA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
NVTA Income Statement
NVTA Balance Sheet
NVTA Cash Flow
Recent trades of NVTA by members of U.S. Congress
NVTA Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
NVTA Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
NVTA Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NVTA's directors and management
Government lobbying spending instances
-
$90,000 Feb 02, 2024 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$90,000 Oct 16, 2023 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$90,000 Jul 10, 2023 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$90,000 Jan 03, 2023 Issue: Budget/Appropriations Consumer Issues/Safety/Products Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$90,000 Oct 17, 2022 Issue: Consumer Issues/Safety/Products Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$90,000 Jul 19, 2022 Issue: Consumer Issues/Safety/Products Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$90,000 Apr 20, 2022 Issue: Health Issues Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$90,000 Jan 19, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$80,000 Oct 20, 2021 Issue: Budget/Appropriations Copyright/Patent/Trademark Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$75,000 Jul 16, 2021 Issue: Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark
-
$20,000 Jun 23, 2021 Issue: Health Issues
-
$30,000 Apr 20, 2021 Issue: Health Issues
-
$75,000 Apr 15, 2021 Issue: Medicare/Medicaid Copyright/Patent/Trademark Medical/Disease Research/Clinical Labs
-
$30,000 Jan 20, 2021 Issue: Health Issues
-
$65,000 Jan 19, 2021 Issue: Budget/Appropriations Medicare/Medicaid Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark Health Issues
-
$60,000 Oct 20, 2020 Issue: Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Oct 16, 2020 Issue: Health Issues
-
$20,000 Jul 20, 2020 Issue: Health Issues
-
$60,000 Jul 20, 2020 Issue: Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$60,000 Apr 17, 2020 Issue: Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$60,000 Jan 15, 2020 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$58,000 Oct 11, 2019 Issue: Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark
-
$37,500 Jul 21, 2019 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations Copyright/Patent/Trademark
-
$20,000 Apr 08, 2019 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$40,000 Mar 12, 2019 Issue: Health Issues
-
$40,000 Jan 18, 2019 Issue: Health Issues Budget/Appropriations
-
$40,000 Oct 19, 2018 Issue: Health Issues Budget/Appropriations
-
$40,000 Jul 18, 2018 Issue: Budget/Appropriations Health Issues
-
$40,000 Apr 16, 2018 Issue: Health Issues Budget/Appropriations
-
$40,000 Jan 22, 2018 Issue: Health Issues
-
$40,000 Oct 05, 2017 Issue: Health Issues
-
$40,000 Jul 19, 2017 Issue: Health Issues
-
$20,000 Apr 18, 2017 Issue: Health Issues
-
$20,000 Jul 14, 2015 Issue: None
-
$30,000 Apr 23, 2015 Issue: Health Issues
-
$10,000 Jan 16, 2015 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 Jan 16, 2015 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 Oct 16, 2014 Issue: Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
- $159,600 2023-10-01 00:00:00 Agency: Department of Veterans Affairs
- $25,000 2023-08-23 00:00:00 Agency: Department of Health and Human Services
- $9,595 2023-06-08 00:00:00 Agency: Department of Veterans Affairs
- $14,725 2022-11-30 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $159,600 2022-10-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $82,350 2022-06-30 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $63,500 2022-03-17 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $159,600 2021-10-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $38,963 2021-09-10 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $82,500 2021-06-17 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $14,250 2021-05-20 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $641,360 2021-02-10 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $159,600 2020-10-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $390,900 2020-10-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2020-09-06 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $450,000 2020-03-30 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of NVTA in WallStreetBets Daily Discussion
NVTA News
Recent insights relating to NVTA
CNBC Recommendations
Recent picks made for NVTA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NVTA
NVTA Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
NVTA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NVTA Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More